Autopsy report · NCT02415595
Dose-finding Study of BMS-955176 to Treat HIV-1 Infected Treatment-naive Adults
Cause of deathOther
“The trial ended early due to GI intolerability and treatment-emergent resistance.”
Life of this trial
- Registered 2 months before it started.
- Ran for about 2 years 3 months before it stopped.
- 210 participants enrolled.
- Results were posted on the registry 1 year 1 month after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- ViiV Healthcare
- Sponsor type
- Industry
- Conditions
- Infection, Human Immunodeficiency Virus
- Interventions
- BMS-955176; EFV; TDF/FTC
- Participants
- 210
- Sites
- 64
- Countries
- Argentina, Canada, Chile, France, Germany, Italy, Mexico, Poland, South Africa, Spain, United Kingdom, United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.